The Impact of Sleep Restriction on Gastric Emptying, Appetite and Energy Intake
1 other identifier
interventional
12
1 country
1
Brief Summary
This study aims to examine if partial sleep deprivation results in alterations blood markers and subjective markers of homeostatic, and hedonic appetite, as well as provide initial data as to the impact of sleep restriction on gastric emptying.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jul 2023
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2023
CompletedStudy Start
First participant enrolled
July 15, 2023
CompletedFirst Posted
Study publicly available on registry
July 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2024
CompletedDecember 15, 2023
December 1, 2023
6 months
March 14, 2023
December 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Fasting blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine
A fasting blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed.
Comparisons in fasting blood markers will be made between sleep restricted vs control conditions. A fasted blood sample will be collected during the 5 minute period from 08:10 - 08:15
Difference in postprandial blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine for a breakfast meal
8 blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between sleep restricted vs control conditions for the area under curve (AUC) for the 3 hour postprandial period.
Following the ingestion of a breakfast meal at 08:15, blood will be drawn every 15 minutes until 1 hour postprandially, then every 30 minutes until 3 hours postprandially.
Difference in postprandial blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine for a lunch-time meal
8 blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between sleep restricted vs control conditions for the area under curve (AUC) for the 3 hour postprandial period.
Following the ingestion of a lunchtime meal at 12:30, blood will be drawn every 15 minutes until 1 hour postprandially, then every 30 minutes until 3 hours postprandially.
Difference in postprandial blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine for an evening meal
8 blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between sleep restricted vs control conditions for the area under curve (AUC) for the 3 hour postprandial period.
Following the ingestion of an evening meal meal at 16:45, blood will be drawn every 15 minutes until 1 hour postprandially, then every 30 minutes until 3 hours postprandially.
Difference in diurnal blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine
27 blood samples will be collected in EDTA and Heparin vacutainers throughout the day, in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between the area under curve (AUC) for the entire diurnal period (11.45 hours), for the sleep restricted vs control conditions.
Blood samples will be drawn at 08:10, and continue to be drawn at regular intervals of 15, 30 and 60 minutes until 20:00.
Secondary Outcomes (16)
Difference in gastric emptying of an evening meal
Every 15 mins for 2 hours following test meal. Comparisons will be made between sleep restricted and control conditions.
Difference in subjective feelings of appetite in a fasted state
Ratings of fasting subjective appetite will be collected during the 5 minute period elapsed from 08:10 - 08:15. Comparisons will be made between sleep restricted vs control conditions.
Difference in subjective feelings of appetite following a breakfast meal
Every 30 minutes up until 3 hours postprandially, following the ingestion of the test meal at 08:15.
Difference in subjective feelings of appetite following a lunch time meal
Every 30 minutes up until 3 hours postprandially, following the ingestion of the test meal at 12:30.
Difference in subjective feelings of appetite following an evening meal
Every 30 minutes up until 3 hours postprandially, following the ingestion of the test meal at 16:45
- +11 more secondary outcomes
Study Arms (2)
Restricted sleep on blood markers and subjective markers of homeostatic, and hedonic appetite
EXPERIMENTALThe proposed study will take the form of a within-subjects, randomized crossover experimental design. The data will be quantitative. The study will take place for total of approximately 5 weeks / 37 days (+ up to 6 weeks depending on their schedule: Minimum duration = 5 weeks (37 days), Maximum duration = Approximately 11 weeks (79 days).
Restricted sleep on gastric emptying
EXPERIMENTALThe proposed study will take the form of a within-subjects, randomized crossover experimental design. The data will be quantitative. The study will take place for total of approximately 5 weeks / 37 days (+ up to 6 weeks depending on their schedule: Minimum duration = 5 weeks (37 days), Maximum duration = Approximately 11 weeks (79 days).
Interventions
The proposed study will take the form of a within-subjects, randomized crossover experimental design. The data will be quantitative.
Eligibility Criteria
You may qualify if:
- Healthy (As assessed with medical screening questionnaire)
- Self-reported habitual bedtimes between 7 to 9 hours (As assessed with the Pittsburgh sleep quality index)
- Between the ages of 18 to 45
You may not qualify if:
- Participants will also be excluded from participation if they are pregnant.
- Current smokers
- Excessive alcohol (\>2 drinks per day)
- Excessive caffeine (\>300mg per day)
- Musculoskeletal injury.
- Shift work during the past 4 weeks
- Travel across more than one time zones during the past 4 weeks.
- An indication of having a depressed mood (As assessed by a score on the Centre for Epidemiologic Studies of Depression scale above 16).
- Moderately or highly physically active, as determined by the International Physical Activity Questionnaire (IPAQ) short form.
- Excessive daytime sleepiness as measured by the Epworth Sleepiness Scale (Score \> 10) (ESS) (Hart et al., 2015).
- Participants will also be considered ineligible if they achieve a score indicative of narcolepsy or chronic insomnia, as assessed through the Pittsburgh Sleep Quality Index \[PSQI\] (Score \> 5) (Hart et al., 2015).
- Participants must achieve a score \< 50 on the Food Craving Questionnaire-Trait-reduced (FCQ-T-r), which has been shown to discriminated between individuals with and without "food addiction" with high sensitivity (85%) and specificity (93%) (Meule et al., 2014).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northumbria university
Newcastle upon Tyne, Tyne and Wear, NE3 1YF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2023
First Posted
July 20, 2023
Study Start
July 15, 2023
Primary Completion
January 17, 2024
Study Completion
January 17, 2024
Last Updated
December 15, 2023
Record last verified: 2023-12